What is new in the early health technology assessment's new definition?

Abstract

Early health technology assessment (HTA) has recently been defined as a process for evaluating the "potential value" of technologies at early development stages. This analysis examines how value is characterized in early stages compared to standard HTA. Using the MAPS framework (Methods, Attributes, Procedures, and Social Preferences), the findings indicate that a broader value framework may be applicable to early HTA relative to standard HTA. This framework includes systematic consideration of attributes beyond health-related benefits, such as real option value and innovation, as well as additional methods like fiscal impact analysis and social return on investment. Additionally, there is potential for less variation in early HTA processes globally, given that these assessments are less tied to local funding decisions. Finally, the role of social preferences in early HTA may also involve considering trade-offs and impact modifiers that are particularly relevant in initial stages, and which deserve further research.